Aditxt (NASDAQ:ADTX) Stock Price Up 8% – Here’s What Happened

Shares of Aditxt, Inc. (NASDAQ:ADTX) were up 8% on Monday . The company traded as high as $0.7999 and last traded at $0.7030. Approximately 336,925 shares changed hands during trading, a decline of 91% from the average daily volume of 3,791,170 shares. The stock had previously closed at $0.6510.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aditxt in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Aditxt Stock Performance

The company has a 50 day simple moving average of $1.30 and a two-hundred day simple moving average of $48.15. The firm has a market cap of $513,190.00, a PE ratio of 0.00 and a beta of 1.49.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.